Replies to post #73658 on ViaDerma Inc (VDRM)

[gameccks1]

You are correct. I was just rechecking in advance of posting the same regarding inventory.

Since online sales resumed in December 2022, through 1Q24, a piddling total of $1,636 has been recorded on Consolidated Statement of Operations. With the 3-7 years out of date nature of significant textual information in financial reports, best guess is the minuscule revenue is from the agreement with Viaderma Distribution, Inc (formerly Biogenx, Inc.). The agreement is for Viaderma to receive 50% of gross profit plus 5% gross sales as licensing fee. Thus, the underlying online sales have been nominal to minimal. Out of pocket price point of $99, now $149, without predicted medicare/medicaid/insurance and fsa/hsa otc approval, severely limits prospective customer base. Viaderma Distribution, Inc. would be carrying inventory, if there was any, on their balance sheet.